2025-07-11T12:33:07-07:00 2024-12-31 541972062 DUNHAM AUKAMP & RHODES PLC 4443 BROOKFIELD CORPORATE DRIVE SUI CHANTILLY VA 20151 990 2024-01-01 426100157 HEARING INDUSTRIES ASSOCIATION INC HEAR 2029750905 1301 K STREET NW 300-W WASHINGTON DC 20005 BRIDGET DOBYAN Executive Director 2025-07-11 true true MICHAEL D AUKAMP CPA P00723879 7036318940 2024 2025-03-06 01:10:19Z BRIDGET DOBYAN 1301 K STREET NW 300-W WASHINGTON DC 20005 2015375 false X WWW.BETTERHEARING.ORG X 1955 DC Trusted voice on hearing health care for product innovation, patient safety and education and public policy. 5 5 4 20 0 2269021 1934769 37450 20655 43156 0 2289676 2015375 0 0 792051 429398 0 0 1566796 1401146 2358847 1830544 -69171 184831 1389217 1754237 256905 437094 1132312 1317143 Trusted voice on hearing health care for product innovation, patient safety and education and public policy. false false Monitor and advise members on federal and state legislation and agencies regarding the legal and regulatory environment of hearing aids. Maintain data on hearing aid devices for members. Provide education and awareness of the importance of hearing health to consumers and coordinate these activities with professional and consumer organizations through the Hear Well Stay Vital campaign activities. research and publication of MarkeTrak, a longitudinal study of the consumer journey that provides unique data on hearing difficulty, hearing aid usage, and adoption rates. Lobbying activity to increase awareness and education of hearing health and follow-up to the passage of the OTC Hearing Aid Act passed in 2017 and proposed legislation for Medicare coverage for hearing health. false false false true false false false false false true false false false true true true false false false false false false false false false false false false true false false false false false false false false false false false false false false true 6 0 false 4 true false false false false false false false false X 5 5 false false false false true true true true true false false true true true true false true false false false DC X THE ORGANIZATION 2029750905 1301 K STREET NW SUITE 300-W WASHINGTON DC 20001 BRIDGET DOBYAN Executive Dir. 40.00 0.00 X 225000 0 0 BRANDON SAWALICH VICE CHAIR 1.00 0.00 X X 0 0 0 MIKKEL KNUDSEN Director 1.00 0.00 X 0 0 0 CARSTEN BUHL Treasurer 1.00 0.00 X 0 0 0 GARY ROSENBLUM Director 1.00 0.00 X X 0 0 0 SANDY BRANDMEIER Chairman 1.00 0.00 X X 0 0 0 225000 1 false true false APCO WORLDWIDE 1299 PENNSYLVANIA AVE NW SUITE 300 WASHINGTON DC 20004 MEDIA CAMPAIGNS 617432 THE VOGEL GROUP 15405 JOHN MARSHALL HWY HAYMARKET VA 20169 LOBBYING EXPENSE 150039 2 1934769 1934769 ANNUAL MEETING 611710 37450 37450 37450 43156 43156 0 0 0 0 0 0 0 0 2015375 37450 43156 0 0 0 0 225000 202500 22500 0 171186 153651 17535 0 4440 3961 479 28772 25895 2877 0 0 13317 13317 150039 150039 0 0 68957 65632 3325 0 4352 3912 440 0 0 25640 23049 2591 31407 31407 0 93152 93152 0 0 423 423 4354 4354 JOINT CAMPAIGN 964633 964633 DUES & MEMBERSHIP 21839 21839 WEBSITE 20650 20650 MISCELLANEOUS 1212 1212 1171 1053 118 1830544 1761796 68748 0 345747 669438 1014924 1028711 0 0 1548 3548 0 3442 0 1264 1335 5743 4933 1233 810 0 0 0 0 24501 46953 1389217 1754237 86155 116667 150000 300000 20750 20427 256905 437094 X 1132312 1317143 1132312 1317143 1389217 1754237 184831 X false true X true false false false false false 1934769 172500 172500 193477 5743 4933 810 810 LEASE LIABILITY 20427 20427 X 2015375 2015375 2015375 1830544 1830544 1830544 Part X : FIN48 Footnote As of December 31, 2024, The Association has no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. The tax years subject to examination by the taxing authorities are the years ended December 31, 2021 through 2023. X X false false false BRIDGET DOBYAN Executive Dir. 225000 225000 Form 990, Part VI, Section A, Line 6 Member means a United States domiciled entity or a foreign domiciled entity having a business location in the United States which is engaged in a Hearing Health Business and is compliant with all (i) laws, rules and regulations promulgated by federal and state authorities having jurisdiction, including, without limitation, the United States Food and Drug Administration, Federal Trade Commission and Federal Communications Commission; and (ii) policies of the Corporation. Form 990, Part VI, Section A, Line 7a Directors shall be elected at the annual meeting of Members. Nominations of persons submitted to the Members for election as Directors, including persons to fill expiring terms or newly created directorships, shall, except as otherwise provided in the Corporation's Bylaws, originate with the Nominating Committee. Directors shall hold office for two-year terms which commence on July 1 of the year of election and end on the second anniversary thereof; provided, however, that any Director elected to fill an unexpired term (whether resulting from the death, resignation or removal or created by an increase in the number of Directors) shall hold office until the next annual meeting of Members at which the election of Directors is in the regular order of business and until her/his successor is elected or appointed and qualified. Directors may be elected to any number of consecutive terms. Form 990, Part VI, Section A, Line 7b The following actions may not be taken without approval of the Members: (a) a plurality of the votes cast at a meeting of the Members is required for the election of Directors; (b) a majority of the votes cast at a meeting of Members is required for (i) any amendment of the Certificate of Incorporation, or (ii) a petition for judicial dissolution of the Corporation; and (c) two-thirds of the votes cast at a meeting of Members is required for (i) disposing of all or substantially all of the assets of the Corporation, (ii) approval of a plan of merger, (iii) authorization of a plan of non-judicial dissolution, or (iv) revocation of a voluntary dissolution proceeding, provided, however, that the affirmative votes cast in favor of any action described in this subsection (c) shall be at least equal to the minimum number of votes necessary to constitute a quorum. Blank votes or abstentions shall not be counted in the number of votes cast. Form 990, Part VI, Section B, Line 11b FORM 990 IS PROVIDED TO THE EXECUTIVE DIRECTOR WHO DISSEMINATES TO THE TREASURER AND BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. Form 990, Part VI, Section B, Line 12c CONFLICT OF INTEREST POLICY IS REVIEWED ON A REGULAR BASIS AT BOARD OF DIRECTORS MEETINGS AND MEMBERS ARE REQUIRED TO DISCLOSE POTENTIAL CONFLICTS OF INTEREST ANNUALLY ON A WRITTEN CONFLICT OF INTEREST STATEMENT Form 990, Part VI, Section C, Line 19 DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS MAY BE MADE AVAILABLE UPON REQUEST TO THE HEARING INDUSTRIES ASSOCIATION'S OFFICE